News Genmab A/S

Equities

Real-time Estimate Cboe Europe Other stock markets 03:51:57 2024-04-29 EDT			5-day change	1st Jan Change
1,982 ^DKK	+1.42%		-2.66%	-8.31%

04-16	Genmab, Johnson & Johnson Logs Higher Q1 Sales for Blood Cancer Drug	MT
04-16	Genmab A/S Announces DARZALEX Sales Results for the First Quarter of 2024	CI

Transactions in Connection with Share Buy-back Program Genmab	04-22	GL
Transactions in Connection with Share Buy-back Program Genmab	04-22	AQ
Genmab, Johnson & Johnson Logs Higher Q1 Sales for Blood Cancer Drug	04-16	MT
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024	04-16	GL
Genmab A/S Announces DARZALEX Sales Results for the First Quarter of 2024	04-16	CI
Transactions in Connection with Share Buy-back Program Genmab	04-15	GL
Health Care Slips on Risk Bias -- Health Care Roundup	04-11	DJ
Transactions in Connection with Share Buy-back Program	04-08	GL
Health Care Flat on Rotation to Rate-Sensitive Sectors -- Health Care Roundup	04-03	DJ
News Highlights : Top Company News of the Day - Wednesday at 11 AM ET	04-03	DJ
ADC oncology acquisition to address solid tumours	04-03	AQ
Global markets live: Swiss Re, Intel, Walt Disney, Paramount, Microsoft...	04-03
News Highlights : Top Company News of the Day - Wednesday at 9 AM ET	04-03	DJ
Correction to Genmab Article	04-03	DJ
Genmab: acquisition of ProfoundBio greeted without emotion	04-03	CF
News Highlights : Top Company News of the Day - Wednesday at 7 AM ET	04-03	DJ
Genmab A/S Re-Affirms Revenue Guidance for the Year 2024	04-03	CI
Transcript : Genmab A/S, ProfoundBio - M&A Call	04-03
European Midday Briefing : Stocks Continue to Struggle Despite Cooling Inflation	04-03	DJ
News Highlights : Top Company News of the Day - Wednesday at 5 AM ET	04-03	DJ

No results for this search

GENMAB : Genmab is available at a bargain price

March 04, 2024 at 06:10 am